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Abstract
Background: Establishment of telomere maintenance mechanisms is a universal step in tumor development to
achieve replicative immortality. These processes leave molecular footprints in cancer genomes in the form of
altered telomere content and aberrations in telomere composition. To retrieve these telomere characteristics from
high-throughput sequencing data the available computational approaches need to be extended and optimized to
fully exploit the information provided by large scale cancer genome data sets.
Results: We here present TelomereHunter, a software for the detailed characterization of telomere
maintenance mechanism footprints in the genome. The tool is implemented for the analysis of large cancer
genome cohorts and provides a variety of diagnostic diagrams as well as machine-readable output for
subsequent analysis. A novel key feature is the extraction of singleton telomere variant repeats, which
improves the identification and subclassification of the alternative lengthening of telomeres phenotype. We
find that whole genome sequencing-derived telomere content estimates strongly correlate with telomere
qPCR measurements (r = 0.94). For the first time, we determine the correlation of in silico telomere content
quantification from whole genome sequencing and whole genome bisulfite sequencing data derived from
the same tumor sample (r = 0.78). An analogous comparison of whole exome sequencing data and whole
genome sequencing data measured slightly lower correlation (r = 0.79). However, this is considerably improved
by normalization with matched controls (r = 0.91).
Conclusions: TelomereHunter provides new functionality for the analysis of the footprints of telomere
maintenance mechanisms in cancer genomes. Besides whole genome sequencing, whole exome sequencing
and whole genome bisulfite sequencing are suited for in silico telomere content quantification, especially if
matched control samples are available. The software runs under a GPL license and is available at https://www.
dkfz.de/en/applied-bioinformatics/telomerehunter/telomerehunter.html.
Background
Telomeres are nucleoprotein complexes at the ends of
eukaryotic chromosomes. In humans, telomeric DNA
consists mainly of non-coding t-type (TTAGGG) re-
peats. However, c- (TCAGGG), g- (TGAGGG) and
j-type (TTGGGG) telomeric variant repeats (TVRs) as
well as other variations of the hexameric sequence exist
[1–3]. Telomeres shorten with each cell division [4] and
once a critical telomere length is reached, a DNA dam-
age response is triggered, resulting in cellular senescence
or apoptosis [5, 6].
To circumvent the limited number of possible cell di-
visions, tumors employ activation of telomerase [7] or
alternative lengthening of telomeres (ALT) [8] as telo-
mere maintenance mechanisms (TMMs). Telomerase is
an enzyme that adds t-type repeats to the chromosome
ends [9]. In contrast, ALT is based on recombination of
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telomeric regions and results in several characteristics,
including telomeres of heterogeneous length [8] and se-
quence composition [3, 10].
These TMMs are crucial for tumorigenesis, making
them valuable drug targets for cancer therapy [11].
However, to precisely identify and interfere with
these mechanisms in various tumor types, more
insight into the different telomere structures is
needed. In the last decades, several experimental
methods have been established to assess telomere
length and ALT status, e.g. telomere qPCR, terminal
restriction fragment (TRF) analysis and C-circle
assay [12, 13].
With the advance of massively parallel sequencing,
an alternative method for measuring telomere content
has emerged. Several studies showed that the number
of short reads containing telomeric repeats can be
used to estimate telomere content in whole genome
sequencing (WGS) data, yielding results comparable
to those of established experimental methods [10, 14–
18]. This type of analysis yields valuable insight into
telomeric features in cancer data as described in sev-
eral recently published cancer studies [19–21]. Here,
we present TelomereHunter, a new computational
tool for determining telomere content that is specific-
ally designed for matched tumor and control pairs. In
contrast to existing tools, TelomereHunter takes
alignment information into account and reports the
abundance of variant repeats in telomeric sequences.
We introduce the main features of TelomereHunter,
discuss the interpretation of exemplary results for
ALT-positive and ALT-negative tumor samples,
characterize the tool in comparison to biological as-
says for telomere content estimation and assess the
impact of different sequencing protocols on the telo-
mere content quantification.
Results
Software features
In the first analysis step, TelomereHunter extracts reads
with a high telomeric repeat content from next-gener-
ation sequencing data in BAM format. The
pre-configured selection criteria use a threshold of at
least six t-type, c-type, g-type or j-type hexameric re-
peats or their reverse complements to classify a 100 bp
long read as telomeric. This threshold is automatically
adjusted for other read lengths. The selection threshold
as well as the search patterns are adaptable. Further-
more, non-consecutive (default) or consecutive appear-
ance of these search patterns can be configured. In the
second step, alignment information from the BAM file is
applied to subclassify selected reads into the four cat-
egories: intratelomeric, junction spanning, subtelomeric
and intrachromosomal (Fig. 1a).
The intratelomeric reads are further analyzed to quan-
tify their TVR content and the presence of singletons,
which are TVRs embedded in canonical t-type repeats.
This analysis of the singleton TVR count is instrumental
for distinguishing telomeric from unmappable subtelo-
meric reads (Fig. 1b).
To calculate the normalized GC-corrected telomere
content for a BAM file as previously described by Ding et
al. [14], the number of intratelomeric reads is normalized
by the number of reads of comparable GC content (48–
52%) and multiplied by 106, a unit that we abbreviated by
TRPM (telomeric reads per GC content-matched million
reads). If a matched control sample is available, the telo-
mere content tumor/control log2 ratio (log2 T/C) is
computed.
Next, the tool performs a comprehensive analysis of
the determined TVR count of tumor and matched con-
trol samples specifically for intratelomeric reads, illus-
trated here by an ALT-positive (Fig. 2) and an
ALT-negative (Fig. 3) sample. This comprises the contri-
bution of t-type and TVRs to the GC-corrected telomere
content (Figs. 2a and 3a), the distribution of telomeric
hexamer counts per intratelomeric read (Figs. 2b and
3b), the log2 T/C of TVRs in arbitrary context (Figs. 2c
and 3c) and of singleton TVRs (Figs. 2d and 3d).
It is noteworthy that a considerable number of reads
containing TVRs are frequently classified as intrachro-
mosomal, usually originating from pseudotelomeric re-
gions. To support the analysis of these regions, the
distribution of subtelomeric, junction spanning and
intrachromosomal reads across individual chromosomes
are summarized in an additional diagram (Additional file
1: Figure S1). By using aligned reads (BAM files) instead
of unaligned reads (FASTQ files) as input to Telomere-
Hunter, this potential noise is removed from the analysis
of intratelomeric reads. Thereby, the detection of
ALT-characteristic aberrations in the TVR distribution is
improved.
A complete overview of all parameters as well as
the generated visualizations and data files is given in
Additional file 1: Tables S1 and S2, respectively. The
run time of TelomereHunter depends on the size of
the BAM file (Additional file 1: Table S3). The soft-
ware and documentation is available at https://www.
dkfz.de/en/applied-bioinformatics/telomerehunter/telo-
merehunter.html.
Application of TelomereHunter
As an exemplary application of TelomereHunter we
compared an ALT-positive and an ALT-negative case
from the ICGC PedBrain project. Based on C-circle and
TRF assays, patient GBM56 [22] was classified as an
ALT-positive glioblastoma case, in which alterations of
telomere content and composition were particularly
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pronounced. The GC-corrected telomere content was
doubled in the tumor samples compared to the matched
control. Our analysis reveals that this extension of telo-
mere repeats is due to an increase of the canonical
t-type repeats, and a gain of particular TVRs (Fig. 2a).
No pronounced shift in the frequency of hexameric re-
peats per telomeric read was detected (Fig. 2b). While
only the c-type repeat log2 T/C was increased among the
TVRs in arbitrary context (Fig. 2c), many singleton
TVRs were strongly enriched in the tumor sample (Fig.
2d). Recombination events that span the t-type rich telo-
meres as well as part of the proximal subtelomeric re-
gion could rationalize these observations, as for instance
shown in Varley et al. [3].
In contrast, the tumor sample of medulloblastoma pa-
tient MB79 [23] was ALT-negative according to C-circle
assay and TRF analysis. A characteristic moderate de-
crease of telomere content in the tumor sample was
found in our analysis, which was accompanied by a
stable TVR count (Fig. 3a). This reflects a shortening of
the telomeres, while the TVR-containing subtelomeric
regions remained unaltered. Likewise, the relative num-
ber of hexameric telomere repeats per read is reduced,
which is characteristic for subtelomeric genome regions
that are relatively enriched through the loss of distal
telomeric sequence (Fig. 3b). In consequence, a moder-
ate gain of TVRs in arbitrary context was observed,
while the t-type log2 T/C was negative (Fig. 3c) and the
number of singleton TVRs was reduced (Fig. 3d). A
more comprehensive characterization of telomeric fea-
tures in cancer data can be found in recently published
pan-cancer studies [19–21].
Characterization of software
We characterized the TelomereHunter-based telomere
content quantification by comparing it to established
a
b
Fig. 1 TelomereHunter workflow. a TelomereHunter extracts reads containing telomere repeats from an input BAM file. The reads are sorted by
mapping position into intrachromosomal, subtelomeric, junction spanning and intratelomeric reads. From the intratelomeric reads, telomere
content, telomere variant repeats and singletons are obtained. b Examples of a typical intratelomeric read containing a TGAGGG singleton and a
typical subtelomeric read containing multiple telomere variant repeats in arbitrary context
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experimental methods for telomere content measure-
ment. Nine pediatric brain tumor samples (six medullo-
blastoma and three glioblastoma samples) were
sequenced by whole genome sequencing (WGS). Subse-
quently, the telomere content was determined computa-
tionally by TelomereHunter and also measured by
telomere qPCR and TRF analysis. We included samples
with different ALT status into the analysis (as deter-
mined by TRF and C-circle assay, Additional file 1: Fig-
ure S2) to assess if the TelomereHunter approach
determines the telomere content of both ALT-positive
and ALT-negative samples with high concordance to
biological assays.
The experimentally determined telomere content esti-
mation matched well with the TelomereHunter results
(Additional file 1: Figure S3a) and was highly correlated
for the individual tumor and control samples (r = 0.90 for
qPCR and r = 0.65 for TRF, Pearson correlation). The cor-
relation was further improved by GC correction of the
computationally determined telomere content (r = 0.94
and 0.72, Pearson correlation) (Additional file 1: Figure
S3b). The Pearson correlation of qPCR to TRF
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Fig. 2 Exemplary ALT-positive glioblastoma patient. a GC corrected telomere content: Telomere content of tumor and control sample in reads
per million GC-matched reads. Contributions of TVRs are indicated by color code. b Telomere repeats in intratelomeric reads: Histogram of repeat
units per read for all extracted intratelomeric reads. c Telomere variant repeats (arbitrary context): Overview on log2 T/C of TVRs in arbitrary
context. d Singleton telomere variant repeats: Overview on log2 T/C of TVRs in singleton context
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measurements was r = 0.65 (individual tumor and control
samples) and r = 0.83 (log2 T/C). It has been observed that
several tools for telomere content estimation from cancer
genome data show a comparable performance [18]. We
confirmed this by benchmarking four software tools in
addition to TelomereHunter (Additional file 1: Figure
S3c-d). For all tools, the log2 T/C correlated better with
the experimental measurements than the direct compari-
son of unmatched samples. TRF and qPCR correlate
better with most of the software predictions than with
each other.
The unique alignment-based classification of extracted
reads performed by TelomereHunter filters intratelo-
meric from chromosomal telomere reads. While the im-
pact of this filtering step is relatively minor in samples
with high telomere content, more than 25% of telomeric
reads are aligned to unique genome regions and thus re-
moved from telomere content estimation in samples
with low telomere content (Additional file 1: Figure S4).
Notably, the majority of intratelomeric reads are aligned
with a mapping quality of 0 using the alignment algo-
rithm bwa-mem (Additional file 1: Figure S5).
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Fig. 3 Exemplary ALT-negative medulloblastoma patient. a GC corrected telomere context: Telomere content of tumor and control sample in
reads per million GC-matched reads (RGCM). Contribution of TVR is indicated by color code. b Telomere repeats in intratelomeric reads:
Histogram of repeat units per read for all extracted intratelomeric reads. c Telomere variant repeats (arbitrary context): Overview on log2
T/C of TVRs in arbitrary context. d Singleton telomere variant repeats: Overview on log2 T/C of TVRs in singleton context
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NGS protocol and computational preprocessing
comparison
In cancer research, patient DNA is analyzed by various se-
quencing protocols, such as exome sequencing or special
chemical modifications, for instance to assess cytosine
methylation through bisulfite treatment. We here quanti-
fied the impact of two such sequencing protocols on the
results of TelomereHunter. First, we selected 49 leiomyo-
sarcoma tumor/control sample pairs for which WES data
and telomere content estimations by qPCR were available
[24]. The comparison showed a highly significant correl-
ation (r = 0.91, p < 2.2·10− 16, Spearman correlation of
bwa-mem aligned samples) between the log2 T/C, but a
reduced correlation (r = 0.79, p < 2.2·10− 16, Spearman cor-
relation) for the individual tumor and control samples
(Fig. 4). While the analyzed tumor and matched control
samples were sequenced simultaneously, overall sequen-
cing of the test cohort was conducted at different time
points and thus under slightly varying conditions. Our ob-
servations imply that these batch effects can result in an
increased technical variability when using WES protocols
for direct quantification, but are partially canceled out by
taking the log2 T/C. We then used the leiomyosarcoma
cohort to test the influence of alignment algorithms, the
alignment filter and the focus on t-type repeats during
read extraction on the telomere content estimation (Add-
itional file 1: Figure S6). In summary, telomere content
log2 T/C estimated from the different alignment algo-
rithms bwa-mem and bwa-aln [25, 26] correlate well in a
matched tumor control setting (r = 0.99). In an unmatched
or control-free setting, the impact of the alignment algo-
rithm is more pronounced (r = 0.95). More specifically,
preprocessing with the bwa-mem algorithm results in
telomere content estimates that correlate better with
q-PCR-based telomere content measurements (log2 T/C:
r = 0.91; direct: r = 0.79) than is the case with the bwa-aln
algorithm (log2 T/C: r = 0.90; direct: r = 0.72). Next, in-
cluding uniquely aligned telomeric repeats into the esti-
mation decreased the correlation from 0.91 to 0.90 for
log2 T/C and from 0.79 to 0.73 in the direct setup. In con-
trast, a focus on t-type repeats actually improved the re-
spective correlation to 0.92 and 0.81, and thus is beneficial
in a setting where telomere content analysis is favored
over TVR profiling. Furthermore, the use of different ver-
sions of the reference genome sequence had a minor im-
pact on the estimation (Additional file 1: Figure S7).
The influence of the repeat threshold parameter on
the telomere content estimation was tested using the
leiomyosarcoma WES data and the nine WGS brain can-
cer samples (Additional file 1: Figure S8). The analysis
showed that for WGS and WES data the default param-
eter of 6 repeats per 100 bp read length and higher par-
ameter choices produce a robustly good correlation with
qPCR-based measurements. In contrast, lower threshold
choices reduce the correlation, thus affecting the WES
data more strongly than the WGS data.
Next, we applied TelomereHunter to 34 medullo-
blastoma samples, which were sequenced by WGS as
well as using a WGBS protocol [27]. The bisulfite
treatment converts unmethylated cytosine to uracil
a b
Fig. 4 Telomere content estimation from WES data. a Correlation of telomere content log2 T/C determined by telomere qPCR and TelomereHunter for
WES samples aligned with bwa-mem from 49 leiomyosarcoma patients. b Correlation of qPCR and TelomereHunter results for individual tumor and
control samples of the same patients (shown on a logarithmic scale). The Spearman correlation coefficients are indicated
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and then to thymine during DNA library prepar-
ation. Because the cytosines of the dominant t-type
repeats are unmethylated, the complexity of the anti-
sense strand is reduced from CCCTAA to TTTTAA,
which is not specific enough to be considered during
telomere content quantification. The sense strand is
unaffected due to the absence of cytosine. When ap-
plied to sequencing data produced by WGBS, Telo-
mereHunter therefore depends exclusively on
information from the telomeric sense strand. The
telomere content analysis showed a correlation of
WGS (aligned with bwa-mem) and WGBS data
(aligned with bwa-aln) that surpasses the WGS/WES
correlation for individual samples (r = 0.78, p =
6.0·10− 7, Spearman correlation) (Fig. 5). For the
WGBS cohort, the absolute number of extracted
intratelomeric reads was 2.9-fold increased compared
to the WGS data (3.1-fold increase if corrected for
sequencing depth). This result is counter-intuitive,
given the loss of information from the telomeric
antisense strand. We speculate that the absence of
cytosines in the telomeric sense strand protects telo-
meric sequences from DNA damage during bisulfite
treatments, and thus leads to a relative enrichment
of the telomeric fraction during DNA library prepar-
ation. At the same time, the relative amount of reads
with a GC content around 50% is twentyfold lower
in WGBS data due to the cytosine conversion (0.6%
of all reads in WGBS as compared to 12% in WGS).
Together this leads to higher telomere content
values in WGBS data (mean = 31,782 TRPM) com-
pared to WGS data (mean = 580 TRPM). Despite the
differences in numeric range, these results show that
telomere content estimations from WGBS genomes
are at least as reliable as quantification from WES
data in a control-free study design.
Discussion
TelomereHunter’s main purpose is the efficient analysis
of telomeric sequences in matched case and control ge-
nomes. It produces an array of diagnostic diagrams,
which allow a detailed characterization of the sample’s
telomere content and composition. It furthermore pro-
vides results in machine readable format and enables an
easy aggregation of data from multiple samples into co-
hort studies. Finally, the extracted and subclassified telo-
meric reads are provided as individual BAM files for
customized follow-up analysis.
A currently unique feature of the tool is the usage of
aligned reads for deconvolution of the different genomic
sources of telomere-repeat-containing reads. Further-
more, the distinction of TVRs in singleton context from
mere TVR quantification increases the information con-
tent of the results. This addition is of special relevance
for the study of the ALT phenotype as demonstrated in
a recent pan-cancer study [21].
Computational telomere content estimations derived
by TelomereHunter were in good agreement with ex-
perimental qPCR-based measurements, confirming earl-
ier reports on the consistency of these methods [18].
This is highly relevant for clinical bioinformatics settings
in which only NGS data is available for precision oncol-
ogy diagnosis. Notably, the in silico estimations corre-
lated better with each of the experimental methods than
qPCR and TRF measurements with each other. More-
over, it is important to differentiate telomere content
from telomere length. Telomere content is an observable
value that describes the abundance of telomeric reads in
a sample. To derive an estimate of the average telomere
length from a telomere content estimate additional in-
formation such as the ploidy of the sample genome and
the presence of extrachromosomal telomeric DNA have
to be taken into account. TelomereHunter is not
intended to provide telomere length estimates.
The exemplary results of an ALT-positive and an
ALT-negative brain cancer case illustrate how a number
of recent discoveries [21] are reflected in the output of
TelomereHunter. The distribution of TVRs within indi-
vidual reads and the quantification of singleton TVRs
significantly improves the identification and study of
ALT-positive cancer genomes as compared to a simple
comparison of telomere content.
We have also profiled how telomere content quantifi-
cation is influenced by different sequencing protocols.
Fig. 5 Telomere content estimation from WGBS data. Correlation of
telomere content estimation from WGBS and WGS data of 34
medulloblastoma samples using TelomereHunter. The Spearman
correlation coefficient is indicated
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The absolute number of extracted intratelomeric reads
in a sample is proportional to the robustness of the telo-
mere content estimations. Here, the average of this value
was 32-fold and 111-fold lower respectively for tumor
and control samples in the WES cohort than for the WGS
samples (Additional file 1: Table S4). Under a standard
WES protocol, the main source of telomeric reads are ac-
tually unselected off-target reads. Interestingly, this im-
plies a negative correlation between the quality of the
target capture and the accuracy of the telomere content
quantification. The development of telomere-sensitive
WES protocols through the explicit addition of telomeric
bait sequences would be a logical extension to compensate
this shortcoming. We additionally observe an improved
correlation of WES-based estimations and telomere qPCR
quantification through normalization with a control sam-
ple, which may be related to cancellation of batch effects
assuming that tumor and control samples were sequenced
simultaneously. This observation advocates for the usage
of matched controls especially for WES datasets. The
comparison of software runs with and without
alignment-based read filtering shows that telomere con-
tent estimation is slightly improved by removing reads
that uniquely align to genomic coordinates. As the TRPM
count from this source remains relatively constant, it con-
tributes stronger to the overall count of telomeric reads in
samples with short telomeres. Hence, these samples profit
more strongly from the alignment-based filter. It is of even
higher relevance for the analysis of TVRs in ALT-positive
samples, as telomeric reads of subtelomeric and intra-
chromosomal origin have a much higher heterogeneity in
TVR content (Additional file 1: Figure S1) and thus par-
tially mask the TVR signature of ALT-positive samples.
WGBS data showed acceptable correlations to WGS
data concerning telomere content quantification but suf-
fered from the absence of matched controls in our study.
Furthermore, information on two relevant TVRs, namely
TCAGGG and TTCGGG [20, 21], was lost in WGBS
data due to the bisulfite conversion. Therefore, crucial
information on telomere composition may be underrep-
resented in a WGBS-only study design.
Conclusions
In this study, we have introduced TelomereHunter as a
software tool for analysis of telomere content and com-
position, and have tested it on data from different
next-generation sequencing protocols. Computational
telomere content quantification from WGS data in can-
cer genome analysis was robust and showed excellent
correlations with the experimental analysis. Moreover,
we found that WGBS and WES data were also suited for
telomere content quantification. WES is sensitive to
batch effects and benefits from the availability of
matched controls for telomere content normalization. In
summary, TelomereHunter provides an in-depth
characterization of telomere features and their deregula-
tion in cancer cells from different types of sequencing
readouts. It largely facilitates retrieving this information
in the cohort-based analyses of cancer genomes. Thus,
TelomereHunter extends the computational methods
available for data mining of the increasing amount of
next-generation sequencing data entering clinical routine
towards novel schemes for patient stratification based
on telomere features.
Methods
TelomereHunter implementation
TelomereHunter is written as a python package and takes
BAM files of single samples or matched tumor and con-
trol pairs as input. Several parameters can be set by the
user with the default settings and workflow being de-
scribed in the following. In the first step of TelomereHun-
ter, telomere reads containing at least n non-consecutive
repeats (t-, c-, g- or j-type) are extracted (Fig. 1a). n is cal-
culated for each read depending on the read length with
the following formula: n = floor(read length · 0.06). The
criterion of searching for six non-consecutive repeats in
100 bp reads has been proposed previously [2] and was
also found suitable for the data presented in the present
study.
In the second step, the extracted reads are categorized
depending on the alignment coordinates and mapping
quality. If reads are properly paired, the mapping pos-
ition of the mate is considered for the sorting. In short,
reads mapping to intrachromosomal regions, i.e. all
chromosome bands except the first or last band, are de-
fined as intrachromosomal reads. The subtelomeric frac-
tion comprises telomeric reads mapped to the first or
last band of a chromosome. Telomeric reads from
paired-end data are classified as junction spanning if one
mate maps to a first or last chromosome band and the
other mate is unmapped. All unmapped reads or reads
with a mapping quality lower than the defined threshold
(default: 8) are categorized as intratelomeric.
The telomere content is calculated as the fraction of
intratelomeric reads per million reads. To account for
GC biases in sequencing data, TelomereHunter deter-
mines a GC-corrected telomere content: Instead of nor-
malizing by the total number of reads in the sample, the
intratelomeric reads are divided by the number of reads
with a GC content between 48 and 52%, which is similar
to that of the canonical t-type repeat and has been sug-
gested for the normalization of telomeric reads [14].
TVRs are quantified by searching for NNNGGG hex-
amers in the intratelomeric reads. To avoid counting of
sequencing errors, only hexamers with base qualities of
at least 20 at every position are considered. The TVR
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counts are normalized to the total number of intratelo-
meric reads in the sample.
Next, TelomereHunter extracts the 18 bp sequences on
either side of predefined TVR types by the user and
counts all occurring combinations. Using default settings,
this TVR context analysis is done for the ten most com-
mon TVRs found in a pan-cancer telomere study [21]. A
particular focus is placed on singletons [(TTAG
GG)3-NNNGGG-(TTAGGG)3], whose counts are nor-
malized by the total number of reads in the sample. The
output of TelomereHunter includes several diagrams visu-
alizing the results (see Figs. 2 and 3 and Additional file 1:
Figure S1 for examples).
Whole genome sequencing
The WGS datasets analyzed in this study were obtained
from the ICGC PedBrain Tumor project. Matching
tumor and control samples were collected according to
ICGC guidelines. The DNA libraries were prepared
using Illumina paired-end sample preparation protocols
and sequencing was performed on Genome Analyzer IIx
and Illumina HiSeq 2000 instruments as previously de-
scribed [22, 23]. Reads were aligned to the GRCh37 ref-
erence from 1000 Genomes project using bwa-mem
version 0.7.8 with the option -T 0.
Whole exome sequencing
The leiomyosarcoma WES datasets were obtained from a
study by Chudasama et al. [24]. Matching tumor and con-
trol samples were collected according to World Health
Organization criteria. Exomes were captured using Sure-
Select Human All Exon V5 +UTRs in-solution capture re-
agents (Agilent) and paired-end sequencing (2 × 101 bp)
was performed with an Illumina HiSeq 2500 instrument
as described previously [24]. Reads were aligned to the
GRCh37 reference from 1000 Genomes project using two
different alignment algorithms (bwa-mem version 0.7.8
with the option -T 0 and bwa-aln version 0.6.2 with the
maximum insert size set to 1000 bp). Duplicates were re-
moved in the datasets aligned with bwa-aln using Picard
tools (version 1.90). Five tumor/control sample pairs were
additionally aligned to the hgGRCh38 reference genome
using bwa-mem version 0.7.8 with the option -T 0.
Whole genome bisulfite sequencing
The WGBS datasets were obtained from the ICGC Ped-
Brain Tumor project. Tumor samples were collected ac-
cording to ICGC guidelines. Sequencing and data
processing were performed as described previously [27].
Briefly, the library preparation included bisulfite conver-
sion after adaptor ligation and sequencing was carried out
with an Illumina HiSeq 2000 machine. The data was proc-
essed using MethylCtools. The reads were aligned against
a single index of both in silico bisulfite-converted strands
of the human reference genome (hg19, NCBI build 37.1)
using BWA version 0.6.1-r104 with the non-default pa-
rameters -q 20 -s.
Computational telomere content estimation
Telomere content estimation with TelomereHunter was
calculated with the default settings unless otherwise in-
dicated. Telomere contents without GC correction were
calculated by dividing the intratelomeric reads by all
reads in the sample. Telomere contents without filtering
of aligned reads were calculated by dividing all telomeric
reads by the number of reads with a GC content of 48–
52%. To use exclusively t-type repeats (TTAGGG) for
read extraction, TelomereHunter was run with -r TTAG
GG. To test the influence of different repeat thresholds
on telomere content estimation, TelomereHunter was
run with repeat thresholds from 2 to 16 using the -rt
parameter.
In addition to the TelomereHunter analysis, telomere
content was quantified with four other software tools.
Reads with six TNAGGG repeats were extracted using
Motif Counter (http://sourceforge.net/projects/motif-
counter/) [10] with the parameters -s -u -q 0. TelSeq
version 0.01 [14] was run using default settings and the
mean telomere content of different read groups was
used for the benchmark. Telomere contents were deter-
mined from FASTQ files using Computel version 0.4.1
[15] with default parameters, R version 3.3.1 and sam-
tools version 1.6. Telomerecat version 3.2 [17] was used
with default parameters. In addition to the physical telo-
mere length determined by Telomerecat, a telomere
content was calculated by normalizing the number of
extracted fully telomeric reads (“F1 reads”) to the total
number of reads in the sample.
Telomere quantitative real-time PCR
Telomere qPCR was conducted essentially as described
previously [28, 29]. In short, 10 ng DNA, 1X LightCycler
480 SYBR Green I Master, 500 nM forward primer and
500 nM reverse primer were added per 10 μl reaction.
The primer sequences were: telo fwd, 5′-CGGT
TTGTTTGGGTTTGGGTTTGGGTTTGGGTTTGGG-
TT-3′; and telo rev, 5′-GGCTTGCCTTACCCT-
TACCCTTACCCTTACCCTTACCCT-3′; 36B4 fwd,
5′-AGCAAGTGGGAAGGTGTAATCC-3′; and 36B4
rev, 5′-CCCATTCTATCATCAACGGGTACAA-3′. Cyc-
ling conditions (for both telomere and 36B4 products)
were 10 min at 95 °C, followed by 40 cycles of 95 °C for
15 s and 60 °C for 1 min. A standard curve was used to
determine relative quantities of telomere repeats (T) to
those of the single copy gene (S, 36B4 gene, also known
as RPLP0). The T/S ratio was calculated for each sample
(tumor and control) separately. The log2 ratio of telo-
mere content was determined by dividing the T/S ratio
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of the tumor sample by the T/S ratio of the control sam-
ple. The calculated log2 ratio represents the increase or
decrease in telomere content in tumor versus control
samples.
C-circle assay
The C-circle assay was performed according the proto-
col of Henson et al. [13]. Briefly, 30 ng DNA was com-
bined with 10 μl 2X Φ29 Buffer, 7.5 U Φ29 DNA
polymerase (both NEB), 0.2 mg/ml BSA, 0.1% (v/v)
Tween 20, 1 mM each dATP, dGTP and dTTP and incu-
bated at 30 °C for 8 h followed by 20min at 65 °C. Reac-
tions without addition of polymerase (−pol) were
included as controls. After addition of 40 μl 2X SSC, the
amplified DNA was dot-blotted onto a 2X-SSC-soaked
Roti-Nylon plus membrane (Carl Roth). The membrane
was baked for 20 min at 120 °C and hybridized and de-
veloped using the TeloTAGGG Telomere Length Assay
Kit (Roche). Chemiluminescent signals were detected
using a ChemiDoc MP imaging system (Bio-Rad).
Terminal restriction fragment analysis
For TRF analysis, 4.5 μg genomic DNA of tumor and
blood (control) samples were used, except for the
GBM38 tumor and MB175 control sample, of which
only 2.2 μg and 1.6 μg DNA were available, respect-
ively. Genomic DNA was digested with the restriction
enzymes HinfI and RsaI overnight. The digested DNA
was resolved on a 0.6% agarose gel (Biozym Gold
Agarose) in 1X TAE buffer using the CHEF-DRII
pulsed-field gel electrophoresis system (Bio-Rad) with
the following settings: 4 V/cm, initial switch time 1 s,
final switch time 6 s, and 13 h duration. Southern
blotting and chemiluminescent detection was per-
formed using the TeloTAGGG Telomere Length
Assay Kit (Roche) according to the manufacturer’s in-
structions. The blot was visualized with a ChemiDoc
MP imaging system (Bio-Rad). The telomere content
in each lane was determined by calculating the sum
of intensities in each lane normalized to the amount
of DNA loaded. This correction may not be sufficient
if the difference of loaded DNA is too large. For this
reason, MB175 was excluded from the correlation
analysis of TRF-derived telomere content. It is noted
that qPCR and TRF differ with respect to the
normalization between samples. For telomere qPCR,
the telomere content is normalized to a single copy
gene and thus has an internal control for the amount
of DNA used. This control is lacking for the TRF
analysis where only the total amount of DNA loaded
is measured. Thus, the TRF analysis is more prone to
errors that arise from differences in the amount of
DNA between samples.
Extraction of alignment categories
The number of reads in different alignment categories
was extracted using samtools version 0.1.17. The
number of supplementary alignments in a BAM file
was extracted using samtools view -f 2048 -c. The
number of unmapped reads was extracted using sam-
tools view -F 2048 -f 4 -c. The mapping qualities of
all non-supplementary alignments were extracted
from the fifth field of the BAM file. The number of
reads mapping to sequences other than the reference
genome were extracted from all non-supplementary
alignments for which the reference sequence name
(third field of the BAM file) was not chromosome
1:22, X or Y.
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